沙格雷酯治疗动脉硬化闭塞症血管支架再狭窄临床观察70例
Effectiveness and safety of sarpogrelate on in-stent restenosis after stent implantation in patients with arteriosclerosis obliterans of the lower extremity in 70 cases
摘要
闭塞性动脉硬化症（arteriosclerosis obliterans,ASO）是由动脉粥样硬化性狭窄和闭塞造成的肢体缺血,多发生于双下肢,是糖尿病患者常见并发症,近年来发病率呈上升趋势[1]。ASO患者常有双下肢不适感,伴有麻木、静息痛、间歇性跛行,甚至坏疽、溃疡。
出处
《武警后勤学院学报（医学版）》
CAS
2015年第1期53-55,共3页
Journal of Logistics University of PAP（Medical Sciences）
参考文献13
-
1罗明尧,舒畅.主髂动脉闭塞性疾病外科治疗的现状[J].中国普通外科杂志,2010,19(6):673-676. 被引量：8
-
2Hanawa T. Materials for metallic stents[J]. J Artif Organs, 2009, 12(2):73-79.
-
3Early M, Kelly DJ. The role of vessel geometry and material properties on the mechanics of stenting in the coronary and peripheral arteries[J]. Proc Inst Mech Eng H, 2010, 224(3): 465-476.
-
4Yamashita T, Kitamori K, Hashimoto M, et aL Conjunctive effects of 5HT2 receptor antagonist, sarpogrelate, on thrombolysis with modified tissue plasminogen activator in different laser-induced thrombosis models[J]. Haemostasis, 2000, 30(6):321-332.
-
5Sharma SK, Zahradka P, Chapman D, et al. Inhibition of serotoninindueed vascular smooth muscle cell proliferation by saq3ogrelate[J]. J Phar Exp Ther, 1999, 290(3):1475- 1481.
-
6Norgq'en L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC Ⅱ)[J]. Eur J Vase Endovasc Surg, 2007, 33 Suppl 1:S1-S75.
-
7Peacock JM, Keo HH, Duval S, et al. The incidence and health economic burden of ischemic amputation in Minnesota 2005-2008[J]. Prey Chronic Dis, 2011, 8(6): A141.
-
8Schillinger M, Sabeti S, Loewe C, et al. Bailoon angioplasty versus implantation of nitinol stents in the superficial femoral artery[J]. N Engl J Med, 2006, 354(18):1879-1888.
-
9Monahan TS, Andersen ND, Panossian H, et aL A novel function for cadherin ll/osteoblast-cadherin in vascular smoolh muscle cells: modulation of cell migration and proliferation[J]. J Vasc Surg, 2007, 45(3):581-589.
-
10王佐广,彭晓云,温绍君.盐酸沙格雷酯对血管系统作用的研究进展[J].中国新药杂志,2005,14(4):487-490. 被引量：15
二级参考文献53
-
1李波,房泽慧,张瑛琦.盐酸沙格雷酯治疗糖尿病足表浅性溃疡30例临床分析[J].哈尔滨医药,2008,28(5). 被引量：3
-
2王晓军,刘文星,徐丽梅.沙格雷酯治疗糖尿病下肢动脉硬化性闭塞症的疗效观察——附58例临床报告[J].新医学,2006,37(4):225-227. 被引量：3
-
3王瑞华,金星,吴学君,种振岳,张十一,董典宁.血管腔内介入联合外科手术治疗下肢多节段动脉硬化闭塞症[J].中国普通外科杂志,2006,15(5):324-327. 被引量：39
-
4Heng Guan,Yong-jun Li,Zhang-rong XU,Guang-wei Li,Xiao-hui Guo,Zhi-min Liu,Da-jin Zou,Hui-li Xing,Wei Liu,Zheng-yan Sheng,Hao-ming Tian,Da-long Zhu,De-min YU,Wei-te Zhuang,Lu-lu Chen,Jian-ping Weng.PREVALENCE AND RISK FACTORS OF PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS OVER 50 YEARS OLD IN CHINA[J].Chinese Medical Sciences Journal,2007,22(2):83-88. 被引量：41
-
5De Vries SO, Hunink MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis [ J ]. J Vasc Surg,1997,26(4) : 558 -569.
-
6Lau H, Cheng SW. Long-term outcome of aortofemoral bypass for aortoiliac occlusive disease [ J ]. Ann Acad Med Singapore,2000,29(4) : 434 -438.
-
7Yamazaki I, Karube N, Soma T, et al. Long-term outcomes using vascular grafts sealed with fragmented autologous adipose tissue for aortoiliac occlusive disease [ J ]. J Artif Organs, 2005,8(1) : 67 -70.
-
8Carsten CG, Kalbaugh CA, Langan EM, et al. Contemporary outcomes of iliofemoral bypass grafting for unilateral aortoiliac occlusive disease: a 10-year experience [J].Am Surg, 2008,74(6) : 555 -560.
-
9Martin D, Katz SG. Axillofemoral bypass for aortoiliac occlusive disease[J]. Am J Surg, 2000,180(2) : 100 - 103.
-
10Passman MA, Taylor LM, Moneta GL, et al. Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease[j]. J Vasc Surg, 1996,23(2) : 263 -271.
共引文献41
-
1吴友良.盐酸沙格雷酯片的溶出度研究[J].中国药房,2007,18(31):2458-2459. 被引量：2
-
2曹高忠,傅红兴,张福志,朱新波,汤从容,张秀华,赵艳花.盐酸沙格雷酯渗透泵控释片的研制[J].中国医院药学杂志,2008,28(13):1055-1058. 被引量：7
-
3张永杰,霍鑫,刘兵.下肢动脉闭塞症的治疗[J].中国普通外科杂志,2010,19(12):1274-1275. 被引量：4
-
4张哲,李莉,聂广萍,景硕,丁奎,段志泉.慢性肾下腹主动脉闭塞患者术中下肢血运情况分析[J].中华医学杂志,2012,92(41):2927-2929.
-
5张伟,傅红兴,李慧,蔡娟娟,朱益如,贾雪超.盐酸沙格雷酯不对称膜胶囊的制备及体外释药试验[J].温州医学院学报,2012,42(6):553-555. 被引量：1
-
6无.2型糖尿病患者合并下肢动脉病变的筛查及管理规范[J].中华糖尿病杂志,2013,5(2):82-88. 被引量：93
-
7朱江涛,刘蓉,朱建兵,蔡武,龚建平,孟庆友,李晓强.64排CT显示主髂动脉闭塞侧支循环的临床价值[J].实用放射学杂志,2013,29(6):925-927. 被引量：2
-
8刘国红,郭捷,庞小刚.气相色谱法测定盐酸沙格雷酯有机溶剂残留[J].农产品加工（创新版）（中）,2013(11):72-74.
-
9刘旭阳,赵鹏台,刘佳,张志华,李静,高丽华,贾宁,张彩兰.盐酸沙格雷酯联合前列地尔对早期糖尿病肾病尿白蛋白排泄率的影响[J].现代仪器与医疗,2013,19(6):47-48. 被引量：12
-
10赵丹丹,何月,赵铁柱,王为,沈焕.下肢动脉硬化闭塞症支架置入后服用盐酸沙格雷酯的疗效观察[J].中国医疗前沿,2013,8(20):26-26.
-
1孙黎敏.沙格雷酯致严重出血、血小板减少和肝功能异常[J].药物不良反应杂志,2002,4(3):207-207. 被引量：1
-
2沙格雷酯预防缺血性卒中的作用不如阿司匹林[J].中华医学信息导报,2008,23(15):10-10.
-
3郭建明,谷涌泉,李学锋,郭连瑞,崔世军,吴英锋,佟铸,武欣,张建,汪忠镐.氯吡格雷和沙格雷酯联用致血小板减少[J].药物不良反应杂志,2012,14(1):50-52. 被引量：4
-
4张建礼,孔令金,李宗涛,张涛.盐酸沙格雷酯降解杂质的制备[J].中国抗生素杂志,2016,41(7):538-540. 被引量：1
-
5WHO全球药物不良反应信息(1)[J].药物流行病学杂志,2002,11(5):272-273.
-
6祝雪芬,刘炳胜.右美托咪定联合舒芬太尼用于老年脊柱手术术后镇痛效果观察[J].实用药物与临床,2013,16(7):567-569. 被引量：19
-
7刘茜,汤叶瀛,赵辉,崔美兰,任文刚,刘冠男.液质联用法测定人血浆中沙格雷酯的浓度[J].沈阳药科大学学报,2014,31(7):526-530. 被引量：2
-
8朱保华.老年人口服小剂量阿司匹林致上消化道出血48例分析[J].中国基层医药,2004,11(11):1393-1394. 被引量：3
-
9王玉珍,李翔,许樟荣,朱平,兰颖,史琳涛.沙格雷酯与阿司匹林治疗糖尿病下肢血管病变的随机、对照临床研究[J].中华内分泌代谢杂志,2009,25(6):595-597. 被引量：31
-
10何金明,梁淼,陈寅,黄亚胜.血栓通注射液配合西药治疗动脉硬化闭塞症60例[J].中国医院药学杂志,2004,24(7):428-429. 被引量：1
